Fleebs-Logo
Details werden geladen...

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China | The Manila Times

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

Ähnliche Seiten

https://www.manilatimes.net/2026/06/08/tmt-newswire/pr-newswire/everest-medicines-enters-into-asset-purchase-agreement-with-corxel-pharmaceuticals-to-develop-and-commercialize-lnz100-in-greater-china/2360321

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China | The Manila Times

https://www.manilatimes.net/2026/06/08/tmt-newswire/pr-newswire/everest-medicines-enters-into-asset-purchase-agreement-with-corxel-pharmaceuticals-to-develop-and-commercialize-lnz100-in-greater-china/2360321
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/knight-therapeutics-announces-launch-of-tavalisse-in-mexico/2353197

Knight Therapeutics Announces Launch of TAVALISSE® in Mexico | The Manila Times

https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/knight-therapeutics-announces-launch-of-tavalisse-in-mexico/2353197
https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/rakovina-therapeutics-announces-q1-2026-financial-results-and-provides-corporate-update/2356285

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update | The Manila Times

https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/rakovina-therapeutics-announces-q1-2026-financial-results-and-provides-corporate-update/2356285
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/axsome-therapeutics-announces-settlement-resolving-all-sunosi-solriamfetol-patent-litigation/2357679

Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation | The Manila Times

https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/axsome-therapeutics-announces-settlement-resolving-all-sunosi-solriamfetol-patent-litigation/2357679
https://www.manilatimes.net/2026/05/22/tmt-newswire/pr-newswire/nuance-pharma-announces-ind-clearance-for-actair-pivotal-clinical-trial-in-china/2349777

Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China | The Manila Times

https://www.manilatimes.net/2026/05/22/tmt-newswire/pr-newswire/nuance-pharma-announces-ind-clearance-for-actair-pivotal-clinical-trial-in-china/2349777
https://www.manilatimes.net/2026/06/04/tmt-newswire/pr-newswire/everest-medicines-enters-commercialization-license-agreement-with-mabworks-for-bejescin-in-the-asia-pacific-market/2358616

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market | The Manila Times

https://www.manilatimes.net/2026/06/04/tmt-newswire/pr-newswire/everest-medicines-enters-commercialization-license-agreement-with-mabworks-for-bejescin-in-the-asia-pacific-market/2358616